Oscar Health, Inc. Hits New 52-Week High at $32.05

Oscar Health, Inc. has reached a significant milestone by hitting a new 52-week high of USD 32.05 on July 1, 2026. This achievement marks a notable performance for the small-cap company within the healthcare services industry, reflecting a robust year-over-year performance of 55.53%, significantly outpacing the S&P 500's 20.74% return during the same period. Despite facing challenges, including a history of negative operating profits, Oscar Health's stock has shown resilience. The company currently holds a market capitalization of USD 3,320 million and has a price-to-book ratio of 3.40. However, it is important to note that the company has not declared any dividends and has a negative return on equity of -45.30%. The stock's journey from a 52-week low of USD 10.69 to its current high underscores the volatility and potential risks associated with investing in Oscar Health. As the company continues to navigate its financial landscape, this milestone serves as a key indicator of its market position and performance trends within the healthcare sector.